About
Omar is the Managing Director of Life Sciences for Allied Minds. Omar previously served as a Partner at Oxford Bioscience Partners, a Boston-based venture capital firm with ~$1B under management. He sourced and led the Series A investment in nFocus Neuromedical which commercialized a catheter-based aneurysm therapy and was recently sold to Covidien for ~$100M. He has served on the boards of Flowmedica (renal therapy; sold to AngioDynamics), SmartPill (GI capsule technology; sold to Given Imaging), Coherex (catheter closure of LAA and PFO), Mitralign (percutaneous heart valve repair), and Cambridge Endoscopic Devices (articulating laparoscopic surgical tools). He was the co-founder of Cardima (AF ablation; IPO) and Resolution Medical (cardiac mapping) based in Silicon Valley. He was also the VP of Marketing of MedicaLogic/Medscape, (EMR/HCIT), and served as VP of Business Development at St. Jude Medical (STJ, $5.2B in revenue). He has developed and launched products worldwide. He is
Position in the VCSift Database
- • 5 investors hold the Managing Director, Life Sciences role in VCSift. Omar Amirana is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Omar
Search Investors